Trial Profile
A study investigating the pharmacokinetic and pharmacogenetic of efavirenz in patients with HIV
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Efavirenz (Primary) ; Lamivudine/stavudine; Lamivudine/zidovudine
- Indications HIV infections
- Focus Pharmacodynamics; Pharmacokinetics
- 12 Dec 2015 New trial record